Effect of dopaminergic agents on the secretion of gastrointestinal immunoreactive glucagon in depancreatized dogs.
D000818:Animals; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology*; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D004763:Glucagon-Like Peptides / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D010180:Pancreatectomy; D010646:Phentolamine / Q000494:pharmacology; D011169:Portal Vein; D011433:Propranolol / Q000494:pharmacology; D011863:Radioimmunoassay; D012039:Regional Blood Flow / Q000187:drug effects
D005768:Gastrointestinal Hormones; D004763:Glucagon-Like Peptides; D011433:Propranolol; D006220:Haloperidol; D004298:Dopamine; D010646:Phentolamine